E
Ewa Aleksandrowicz
Researcher at Gdańsk Medical University
Publications - 21
Citations - 452
Ewa Aleksandrowicz is an academic researcher from Gdańsk Medical University. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 12, co-authored 21 publications receiving 424 citations.
Papers
More filters
Journal ArticleDOI
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Leszek Tylicki,Przemysław Rutkowski,Marcin Renke,Wojciech Larczyński,Ewa Aleksandrowicz,Wieslawa Lysiak-Szydlowska,Bolesław Rutkowski +6 more
TL;DR: Administration of an aldosterone receptor antagonist in addition to double RAAS blockade with an ACE inhibitor and ARB may slow the progression of chronic kidney disease.
Journal ArticleDOI
Expression of scavenger receptor CD36 in chronic renal failure patients.
Michał Chmielewski,Ewa Bryl,Lukasz Marzec,Ewa Aleksandrowicz,Jacek M. Witkowski,Bolesław Rutkowski +5 more
TL;DR: Increased expression of CD36 scavenger receptor in CRF patients is demonstrated, for the first time, and may be a possible risk factor for accelerated atherogenesis observed in this group of patients.
Journal ArticleDOI
Renal Allograft Protection with Angiotensin II Type 1 Receptor Antagonists
Leszek Tylicki,B. Biedunkiewicz,A. Chamienia,K. Wojnarowski,Z. Zdrojewski,Ewa Aleksandrowicz,Wieslawa Lysiak-Szydlowska,B. Rutkowski +7 more
TL;DR: Losartan reduces urine excretion of proteins associated with tubular damage and graft fibrosis, and significantly decreased N‐acetyl‐β‐d‐glucosaminidase and alfa‐1 microglobulin excretion relative to placebo and carvedilol.
Journal ArticleDOI
The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs
Leszek Tylicki,Tomasz Nieweglowski,Bogdan Biedunkiewicz,Andrzej Chamienia,Alicja Debska-Slizien,Ewa Aleksandrowicz,Wieslawa Lysiak-Szydlowska,Bolesław Rutkowski +7 more
TL;DR: The study showed that ozonated autohemotherapy with ozone concentration 50 μg/ml per gram of blood induced a significant decrease in glutathione level after 9 sessions of this procedure, and it seems likely that the antioxidant defense system, part of which is glutATHione, neutralizes oxidative properties of ozone in this concentration and protects against oxidative cell damage.
Journal ArticleDOI
Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
Marcin Renke,Leszek Tylicki,Przemysław Rutkowski,Narcyz Knap,Marcin Zietkiewicz,Alexander Neuwelt,Ewa Aleksandrowicz,Wiesława Łysiak-Szydłowska,Michał Woźniak,Bolesław Rutkowski +9 more
TL;DR: Pentoxifylline may decrease proteinuria in non-diabetic patients with CKD and is reported to have promising effects in CKD treatment.